Immunoassays: Technologies and Global Markets

Report Code: BIO033C

Publish Date: Mar 2023

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global immunoassay tests market reached $30.6 billion in 2022 and should reach $39.8 billion by 2027, with a compound annual growth rate (CAGR) of 5.4% during the forecast period of 2022-2027.

Report Includes

  • 124 data tables and 4 additional tables
  • An up-to-date review and analysis of the global markets for immunoassays and related technologies
  • Analyses of the global market trends, with historic sales data for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Estimation of the actual market size and revenue forecast for global immunoassays market in USD millions, and corresponding market share analysis based on product type, application, and region
  • Discussion of the major market dynamics, key shifts and regulations, industry specific challenges, and other region-specific macroeconomic factors affecting the market for immunoassays as a basis for projecting demand over the next few years (2022-2027)
  • Insight into prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent breakthrough innovations, clinical trials, and value chain analyses
  • Assessment of the recent industry structure for microbiome therapeutics, ongoing research (R&D) activities, analysis of the competitive environment, and COVID-19 impact on the biotech industry
  • Review of the patents and patent applications on immunoassays testing and applications
  • Competitive landscape of this market featuring leading biopharmaceutical companies, their product portfolios, financial performances, and market share analysis based on recent segmental revenues
  • Company profiles of major players within the industry, including Abbott Laboratories, Biomerieux S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, and Thermo Fisher Scientific

Report Scope

The report is designed to be a comprehensive business tool to provide an in-depth look at the market for immunoassays. The geographic scope of the report is global. The report reviews each type of immunoassay and reviews technologies associated with immunoassays and equipment. The report also explores market size, identifies market participants and investigates patents in the immunoassays market.

The global market for immunoassays is divided into categories by immunoassay type and by application as follows.

By product:

  • Enzyme immunoassays.
  • Fluorescent immunoassays.
  • Radioimmunoassays.
  • Chemiluminescent immunoassays.
  • Lateral flow immunoassays and multiplex immunoassays.

By application:

  • Diabetes.
  • Drug screening.
  • Infectious diseases.
  • Cancer.
  • Cardiology.
  • Reproductive.
  • Other immunoassays.

Each area is covered in detail, identifying current products in the market in the base year 2021, measuring current market size and identifying current and potential market drivers, forecasting for 2027, assessing current and potential competitors, and identifying current competitor market shares for the base year of 2021.

Report Synopsis

Report Metrics Details
Base year considered 2021
Forecast period considered 2022-2027
Base year market size $29 billion
Market size forecast $39.8 billion
Growth rate CAGR of 5.4% for the forecast period of 2022-2027
Units considered $ Millions
Segments covered Region, Type of Test, Application
Regions covered North America, Europe, Asia-Pacific, Rest of the World (RoW)
Countries covered U.S., Mexico, Canada, Germany, France, U.K., Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, Netherlands, Sweden, Russia, Japan, China, India, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, Philippines, Korea, Indonesia, Middle East, Africa, South America
Key Market Drivers
  • Global Burden of Disease
  • Aging Population
Companies studied
Company ProfilesABBOTT
ABCAM LTD.BECKMAN COULTER INC. (SUBSIDIARY OF DANAHER CORP.)
BIOMERIEUXBIO-RAD LABORATORIES INC.
DIASORIN S.P.A.MERCK & CO. INC.
MINDRAYORASURE TECHNOLOGIES INC.
PERKINELMERQUIDELORTHO CORP.
RANDOX LABORATORIES LTD.F. HOFFMANN-LA ROCHE LTD.
SD BIOSENSORSIEMENS HEALTHINEERS AG
THERMO FISHER SCIENTIFIC INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The immunoassays: technologies and global market is projected to grow from $29.0 billion in 2021 to $39.8 billion in 2027, at a compound annual growth rate (CAGR) of 5.4% during the forecast period.
The key factors driving the growth of immunoassays market is majorly driven by the rising chronic disease such as cancer, diabetes, autoimmune diseases, cardiovascular diseases and infectious diseases such as influenza, HIV, tuberculosis, including COVID-19, technological advancements in immunoassays development, increasing use of immunoassays in oncology due to its specificity in detecting presence of tumour antigens and application of immunoassays in drug discovery and development including toxicology studies, identifying drug responsive biomarkers are the key factors propelling the growth of this market.
The immunoassays: technologies and global market is segmented based on the product type such as EIA, radioimmunoassay, FIA, CLIA, LFI’s & MIA’s by application includes diabetes, infectious disease, drug screening, cancer, cardiology, reproductive, other-immunoassays and by geographic region.
LFI’s & MIA’s will dominate the market by the end of 2027.
Key companies in the market includes Roche Diagnostics, Abbott, Siemens Healthineers, Danaher, Thermofisher-Scientific, Diasorin, bioMérieux, etc.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Latest reports include:
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Immunoassays: Technologies and Global Markets127Free
Chapter- 1: Introduction8Free
Chapter- 2: Summary and Highlights4Free
Chapter- 3: Market Overview5Free
Chapter- 4: Market Dynamics4Free
Chapter- 5: Impact of the COVID-19 Pandemic3Free
Chapter- 6: Global Market for Immunoassays4Free
Chapter- 7: Market Breakdown by Type of Test25Free
Chapter- 8: Market Breakdown by Application36Free
Chapter- 9: Competitive Landscape12Free
Chapter- 10: Patents2Free
Chapter- 11: Company Profiles23Free
Chapter- 12: Appendix: Acronyms1Free

Related Reports

Global Markets for Allergy Diagnostics and Treatments

Published - Jun 2025 | Publisher - BCC Publishing | Code - PHM026D

The global market for allergy diagnostics and treatment is projected to grow from $67.8 billion in 2025 to $96.4 billion by the end of 2030, at a compound annual rate growth (CAGR) of 7.3% from 2025 through 2030.

In Vitro Diagnostics: Technologies and Global Markets

Published - Jan 2025 | Publisher - Partha Sarathi Das | Code - HLC186D

The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.

Plastics in Electronics Components: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - PLS027F

The global plastics used in electronic components market reached $7.9 billion in 2022 and should reach $10.3 billion by 2027, with a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2022-2027.

Global Markets for Treatment and Diagnosis of Sexually Transmitted Diseases

Published - Oct 2020 | Publisher - BCC Publishing | Code - PHM005E

The global market for sexually transmitted disease diagnostics should grow from $7.6 billion in 2020 to $10.6 billion by 2025 at compound annual growth rate (CAGR) of 7.0% for the period of 2020-2025.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 128

  • Summary Table: Global Market for Immunoassay Tests, by Type of Test, Through 2027
  • Table 1: Global Burden of Disease, by Cause, 2019
  • Table 2: Global Population, Aged 60 and Older, 2010-2050
  • Table 3: Global Market for Immunoassay Tests, Through 2027
  • Table 4: Global Market for Immunoassay Tests, by Region, Through 2027
  • Table 5: North American Market for Immunoassay Tests, Through 2027
  • Table 6: North American Market for Immunoassay Tests, by Country, Through 2027
  • Table 7: European Market for Immunoassay Tests, Through 2027
  • Table 8: European Market for Immunoassay Tests, by Country, Through 2027
  • Table 9: Asia-Pacific Market for Immunoassay Tests, Through 2027
  • Table 10: Asia-Pacific Market for Immunoassay Tests, by Country, Through 2027
Sample Report

Recent Reports

Global Biochip Markets: Microarrays and Lab-on-a-Chip

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO049G

The global market for biochip was valued at $16.1 billion in 2024 and is estimated to reach $27.8 billion by 2029, at a compound annual growth rate (CAGR) of 11.6% from 2024 through 2029.

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Top Trending Reports

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Apr-2013| Analyst - Carlet Auguste| Code - BIO033B

Report Highlights

The global demand for immunoassay testing was nearly $15.6 billion in 2011 and $16.3 billion in 2012. This market is expected to grow to $20.5 billion by 2017, at a compound annual growth rate (CAGR) of 4.7% from 2012 to 2017.

Report Includes

  • An overview of the global market for growth of immunoassay technology in clinical, food safety, and environmental areas.
  • Analysis of global market trends, with data provided for 2011 and 2012, and projections, with five-year compound annual growth rates (CAGRs), through 2017.
  • Discussion of government regulations and technology patents and the roles they play in development.
  • Analysis of new markets.
  • Comprehensive company profiles of major players.
Published - Dec-2001| Analyst - Ruth Scolnick| Code - BIO033A

Report Highlights

  • As the human genome-sequencing project nears completion and other organisms' genomes are sequenced, the number of known proteins increases. Many proteins are currently being used and will be used as diagnostic tools in immunoassays. Immunoassays are used in a variety of applications: medical diagnostics, infectious disease testing, drug testing, home use, hormones, veterinary diagnostic, cancer, tissue typing, research, food testing, environmental testing, industrial chemicals, plant disease diagnostics, and biotechnology products testing. Enzyme-linked immunosorbent, chemiluminescent, fluorescent, radio-labeled, and immunoprecipitation are some of the old and new immunoassay technologies being used. New immunoassay technologies are also being developed. Since the number of known proteins and the potential number of immunoassays are increasing, it is interesting to analyze the current and developing immunoassay technologies and markets.
  • This report is an analytical tool whose primary purpose is to show increased growth in the current and emerging clinical, food safety, and environmental immunoassay fields. The report discusses specific, patented technology, the role of government regulation and patents that affect the development and growth of the various immunoassay markets.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Immunoassays: Technologies and Global Markets
Customize Report